APA

Ballantyne C. M., Neutel J., Cropp A., Duggan W., Wang E. Q., Plowchalk D., Sweeney K., Kaila N., Vincent J. & Bays H. (20150626). Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. : The American journal of cardiology.

Chicago

Ballantyne Christie M, Neutel Joel, Cropp Anne, Duggan William, Wang Ellen Q, Plowchalk David, Sweeney Kevin, Kaila Nitin, Vincent John and Bays Harold. 20150626. Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. : The American journal of cardiology.

Harvard

Ballantyne C. M., Neutel J., Cropp A., Duggan W., Wang E. Q., Plowchalk D., Sweeney K., Kaila N., Vincent J. and Bays H. (20150626). Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. : The American journal of cardiology.

MLA

Ballantyne Christie M, Neutel Joel, Cropp Anne, Duggan William, Wang Ellen Q, Plowchalk David, Sweeney Kevin, Kaila Nitin, Vincent John and Bays Harold. Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. : The American journal of cardiology. 20150626.